Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III double-blind randomized trial of aerosolized JH509 in mild COVID-19 outpatients
jRCT2031210448Phase 3Recruiting
- Sponsor
- Genova
- Start
- Jan 2022
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Aerosolized JH509 with Placebo (2 arms). Started Jan 2022; status: recruiting.
02
Drugs
JH509
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on jRCT2031210448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031210448.